Press Releases Orphazyme A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 11:47:45 29/04/2024 BST			5-day change	1st Jan Change
1,090 ^DKK	0.00%		+8.46%	-18.05%

03-27	Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-04	FDA Extends Review of Zevra's Arimoclomol by Three Months	DJ

STALICLA Appoints Dr. Thomas Blaettler, MD	04-12	AQ
BioStock: Comments from Orphazyme on the investment in CombiGene	03-04	AQ
The Danish company Orphazyme has acquired 10% of the shares in CombiGene	02-21	AQ
Myositis Pipeline, Clinical Trials Studies, Agreements & Collaborations, and Latest News 2023 (Updated)	10/10/23	AQ
Niemann-Pick-Disease Pipeline, FDA Approvals, Clinical Trials, and Emerging Drugs 2023 (Updated)	28/09/23	AQ
Change in management	30/05/23	GL
Major shareholder announcement	19/05/23	GL
Major shareholder announcement	17/05/23	GL
Resolutions passed at the Annual General Meeting	17/05/23	GL
Changes to the Board of Directors	17/05/23	AQ
Changes to the Board of Directors	17/05/23	GL
Major shareholder announcement	12/05/23	GL
Major shareholder announcement	09/05/23	GL
Major shareholder announcement	09/05/23	GL
Major shareholder announcement	09/05/23	AQ
Notice to convene Annual General Meeting	25/04/23	GL
Notice to convene Annual General Meeting	25/04/23	AQ
Adjusted financial outlook for 2022	25/09/22	GL
Adjusted financial outlook for 2022	25/09/22	GL
Updated financial calendar for 2022	19/09/22	GL

No results for this search